Aclarion, Inc. (ACON)

0.2899 +0.0045 (+1.58%) 市場開市。 截至 12:20PM EDT。

Aclarion, Inc.

8181 Arista Place
Suite 100
Broomfield, CO 80021
United States
833 275 2266
https://www.aclarion.com

版塊: Healthcare
行業: Health Information Services
全職員工: 4

高階主管

名稱	頭銜	支付	行使價	出生年份
Dr. Jeffrey John Thramann M.D.	Executive Chairman	300k	無	1965

截止 2023年12月31日為止計算的金額，現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 USD。

描述

Aclarion, Inc., a healthcare technology company, leverages for Magnetic Resonance Spectroscopy (MRS) in the United States. It develops NOCISCAN Post-Processor suite of software applications comprising NOCICALC that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra and performs various degenerative pain biomarker; and NOCIGRAM, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was incorporated in 2008 and is based in Broomfield, Colorado.

公司管治

截至 無 止，Aclarion, Inc. 的 ISS 管治質素評分為 無。 Pillar 分數正在審核中：無；董事會：無；股東權利：無；現金賠償：無。

企業管治評分的資料提供： Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險，而 10 分表示較高的管治風險。